Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Mahoney

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Cephalalgia : an International Journal of Headache|June 20, 2012
Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment designTony W Ho, Eric Pearlman, Donald Lewis, et al.
Headache|October 20, 2012
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineursDavid J Hewitt, Eric Pearlman, Mirja Hämäläinen, et al.
The New England Journal of Medicine|May 3, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's DiseaseMichael F Egan, James Kost, Pierre N Tariot, et al.
Brain : a Journal of Neurology|November 30, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brainCyrille Sur, James Kost, David Scott, et al.
The New England Journal of Medicine|April 11, 2019
Randomized Trial of Verubecestat for Prodromal Alzheimer's DiseaseMichael F Egan, James Kost, Tiffini Voss, et al.
Nature Medicine|May 14, 2024
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim resultsJeffrey Sevigny, Olga Uspenskaya, Laura Dean Heckman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Cephalalgia : an International Journal of Headache|June 20, 2012
Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment designTony W Ho, Eric Pearlman, Donald Lewis, et al.
Headache|October 20, 2012
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineursDavid J Hewitt, Eric Pearlman, Mirja Hämäläinen, et al.
The New England Journal of Medicine|May 3, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's DiseaseMichael F Egan, James Kost, Pierre N Tariot, et al.
Brain : a Journal of Neurology|November 30, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brainCyrille Sur, James Kost, David Scott, et al.
The New England Journal of Medicine|April 11, 2019
Randomized Trial of Verubecestat for Prodromal Alzheimer's DiseaseMichael F Egan, James Kost, Tiffini Voss, et al.
Nature Medicine|May 14, 2024
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim resultsJeffrey Sevigny, Olga Uspenskaya, Laura Dean Heckman, et al.
Pageof 2